Lumateperone tosylate
Tier C — Watch / tradeLumateperone tosylate · all drugs expiring in 2031 →
Targets：5-HT2A, DRD2
Brand：Caplyta, CAPLYTA
Indications (approved)：Major depressive disorder, Depression, Schizophrenia
Regional status
Factories producing this API2
Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.
2 producing factories on file — sign in to view the named list (factory details are not shown to guests).
Sign in to view factories →Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| LUMAT-001 | 59564-59-9Available | 3,4-dihydroquinoxalin-2(1H)-one |
| LUMAT-002 | 53374-52-0Available | 4-nitroso-3,4-dihydroquinoxalin-2(1H)-one |
| LUMAT-003 | 29976-53-2Available | ethyl 4-oxopiperidine-1-carboxylate |
| LUMAT-004 | 313544-31-9Available | ethyl 2-oxo-2,3,9,10-tetrahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(7H)-carboxylate |
| LUMAT-005 | 313369-16-3Available | (6bR,10aS)-ethyl 2-oxo-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(9H)-carboxylate |
| LUMAT-006 | 313369-25-4Available | (6bR,10aS)-ethyl 3-methyl-2-oxo-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(9H)-carboxylate |
| LUMAT-007 | 313369-26-5Available | (6bR,10aS)-ethyl 3-methyl-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(9H)-carboxylate |
| LUMAT-008 | 313368-85-3Available | (6bR,10aS)-3-methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline |
| LUMAT-009 | 3874-54-2Available | 4-chloro-1-(4-fluorophenyl)butan-1-one |
Frequently asked questions
What are the approved indications of Lumateperone tosylate?
Approved indications include: Major depressive disorder, Depression, Schizophrenia.
When does the Lumateperone tosylate patent expire?
Based on public sources, the Lumateperone tosylate patent expires in 2031.
How many synthesis routes are recorded for Lumateperone tosylate?
1 synthesis routes are recorded; the shortest is 7 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Lumateperone tosylate intermediates?
9 intermediate CAS of Lumateperone tosylate are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Lumateperone tosylate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29